GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells.
Arif S, Gomez-Tourino I, Kamra Y, Pujol-Autonell I, Hanton E, Tree T, Melandri D, Hull C, Wherrett DK, Beam C, Roep BO, Lorenc A, Peakman M.
Arif S, et al. Among authors: gomez tourino i.
Diabetologia. 2020 Jun;63(6):1186-1198. doi: 10.1007/s00125-020-05130-7. Epub 2020 Apr 4.
Diabetologia. 2020.
PMID: 32248243
Free PMC article.